| 1 |
Short QT syndrome manifesting with neonatal atrial fibrillation and bradycardia.
61
6
|
Villafane J...Gebauer R
|
24818999 |
2014 |
| 2 |
A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene.
61
6
|
Priori SG...Jalife J
|
15761194 |
2005 |
| 3 |
A new KCNQ1 mutation at the S5 segment that impairs its association with KCNE1 is responsible for short QT syndrome.
6
|
Moreno C...Valenzuela C
|
26168993 |
2015 |
| 4 |
Executive summary: HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes.
6
|
Priori SG...Asia Pacific Heart Rhythm Society
|
23994779 |
2013 |
| 5 |
HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).
6
|
Ackerman MJ...European Heart Rhythm Association (EHRA)
|
21810866 |
2011 |
| 6 |
De novo KCNQ1 mutation responsible for atrial fibrillation and short QT syndrome in utero.
6
|
Hong K...Brugada R
|
16109388 |
2005 |
| 7 |
Short QT syndrome and atrial fibrillation caused by mutation in KCNH2.
6
|
Hong K...Brugada R
|
15828882 |
2005 |
| 8 |
Mutation in the KCNQ1 gene leading to the short QT-interval syndrome.
6
|
Bellocq C...Wilde AA
|
15159330 |
2004 |
| 9 |
Sudden death associated with short-QT syndrome linked to mutations in HERG.
6
|
Brugada R...Antzelevitch C
|
14676148 |
2004 |
| 10 |
Short QT Syndrome: a familial cause of sudden death.
6
|
Gaita F...Borggrefe M
|
12925462 |
2003 |
| 11 |
Idiopathic short QT interval: a new clinical syndrome?
6
|
Gussak I...Bjerregaard P
|
11173780 |
2000 |
| 12 |
[Long and short QT syndromes : Emergency treatment and secondary prophylaxis].
61
|
Horn N...Wolpert C
|
32025785 |
2020 |
| 13 |
Ventricular Dysrhythmias During Long-Term Follow-Up in Patients With Inherited Cardiac Arrhythmia.
61
|
Sitorus GDS...de Groot NMS
|
31481179 |
2019 |
| 14 |
Long-term follow-up of implantable cardioverter-defibrillators in Short QT syndrome.
61
|
El-Battrawy I...Akin I
|
30879093 |
2019 |
| 15 |
Drug Testing in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes From a Patient With Short QT Syndrome Type 1.
61
|
Zhao Z...Borggrefe M
|
30947366 |
2019 |
| 16 |
Acquired short QT syndrome in a cancer patient treated with Toad.
61
|
Huang Y...Hu D
|
31037741 |
2019 |
| 17 |
Estimation of economic weights for number of teats and sperm quality traits in pigs.
61
|
Krupa E...Zakova E
|
31515873 |
2019 |
| 18 |
Electrical storm in an acquired short QT syndrome successfully treated with quinidine.
61
|
Spartalis M...Tsoutsinos A
|
31428405 |
2019 |
| 19 |
Pharmacotherapeutic Effects of Quinidine on Short QT Syndrome by Using Purkinje-Ventricle Model: A Simulation Study.
61
|
Luo C...Zhang H
|
31946488 |
2019 |
| 20 |
Modeling Reentry in the Short QT Syndrome With Human-Induced Pluripotent Stem Cell-Derived Cardiac Cell Sheets.
61
|
Shinnawi R...Gepstein L
|
31072576 |
2019 |
| 21 |
Functional and pharmacological characterization of an S5 domain hERG mutation associated with short QT syndrome.
61
|
Butler A...Hancox JC
|
31049424 |
2019 |
| 22 |
Impact of Antiarrhythmic Drugs on the Outcome of Short QT Syndrome.
61
|
El-Battrawy I...Borggrefe M
|
31427960 |
2019 |
| 23 |
An Update on the Structure of hERG.
61
|
Butler A...Dempsey CE
|
32038248 |
2019 |
| 24 |
Differences in Short QT Syndrome Subtypes: A Systematic Literature Review and Pooled Analysis.
61
|
Raschwitz LS...Borggrefe M
|
32010184 |
2019 |
| 25 |
Long-Term Follow-Up of Patients With Short QT Syndrome: Clinical Profile and Outcome.
61
|
El-Battrawy I...Borggrefe M
|
30571592 |
2018 |
| 26 |
Antiarrhythmic effect of antazoline in experimental models of acquired short- and long-QT-syndromes.
61
|
Ellermann C...Frommeyer G
|
29377987 |
2018 |
| 27 |
Action potential clamp characterization of the S631A hERG mutation associated with short QT syndrome.
61
|
Butler A...Hancox JC
|
30175559 |
2018 |
| 28 |
Tentative Screening Criteria for Short QT Interval in Children and Adolescents.
61
|
Hazeki D...Yoshinaga M
|
30047504 |
2018 |
| 29 |
Broad antiarrhythmic effect of mexiletine in different arrhythmia models.
61
|
Frommeyer G...Eckardt L
|
29016765 |
2018 |
| 30 |
Diagnosis and management of short QT syndrome.
61
|
Bjerregaard P
|
29501667 |
2018 |
| 31 |
Computational Analysis of the Action of Chloroquine on Short QT Syndrome Variant 1 and Variant 3 in Human Ventricles.
61
|
Luo C...Zhang H
|
30441573 |
2018 |
| 32 |
Multiple clinical profiles of families with the short QT syndrome.
61
|
Akdis D...Duru F
|
29016797 |
2018 |
| 33 |
Strong sesquiterpene emissions from Amazonian soils.
61
|
Bourtsoukidis E...Williams J
|
29884892 |
2018 |
| 34 |
Emerging therapeutic targets in the short QT syndrome.
61
|
Hancox JC...Zhang H
|
29697308 |
2018 |
| 35 |
Impact of QTc formulae in the prevalence of short corrected QT interval and impact on probability and diagnosis of short QT syndrome.
61
|
Providencia R...Lambiase PD
|
28954836 |
2018 |
| 36 |
Therapeutic effects of a taurine-magnesium coordination compound on experimental models of type 2 short QT syndrome.
61
|
An MY...Lou JS
|
29072257 |
2018 |
| 37 |
Molecular Insights into the Short QT Syndrome.
61
|
Perike S...McCAULEY MD
|
31355049 |
2018 |
| 38 |
Modeling Short QT Syndrome Using Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
61
|
El-Battrawy I...Akin I
|
29574456 |
2018 |
| 39 |
Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients With Short QT Syndrome.
61
|
Mazzanti A...Priori SG
|
29241489 |
2017 |
| 40 |
Loss-of-activity-mutation in the cardiac chloride-bicarbonate exchanger AE3 causes short QT syndrome.
61
|
Thorsen K...Jensen HK
|
29167417 |
2017 |
| 41 |
Genetic causes of sudden cardiac death in children: inherited arrhythmogenic diseases.
61
|
Vacanti G...Mazzanti A
|
28759457 |
2017 |
| 42 |
The new kids on the block of arrhythmogenic disorders: Short QT syndrome and early repolarization.
61
|
Mazzanti A...Priori SG
|
28569435 |
2017 |
| 43 |
Pro-arrhythmogenic Effects of the V141M KCNQ1 Mutation in Short QT Syndrome and Its Potential Therapeutic Targets: Insights from Modeling.
61
|
Lee HC...Cui J
|
29213224 |
2017 |
| 44 |
Modelling the effects of quinidine, disopyramide, and E-4031 on short QT syndrome variant 3 in the human ventricles.
61
|
Luo C...Zhang H
|
28812984 |
2017 |
| 45 |
In silico investigation of a KCNQ1 mutation associated with short QT syndrome.
61
|
Adeniran I...Zhang H
|
28814790 |
2017 |
| 46 |
Modeling the effects of amiodarone on short QT syndrome variant 2 in the human ventricles.
61
|
Cunjin Luo...Henggui Zhang
|
29060841 |
2017 |
| 47 |
Effects of island-distribution of mid-cardiomyocytes on ventricular electrical excitation associated with the KCNQ1-linked short QT syndrome.
61
|
Cunjin Luo...Henggui Zhang
|
29060698 |
2017 |
| 48 |
The Phenotypic Spectrum of a Mutation Hotspot Responsible for the Short QT Syndrome.
61
|
Hu D...Barajas-Martinez H
|
29759541 |
2017 |
| 49 |
Effects of amiodarone on short QT syndrome variant 3 in human ventricles: a simulation study.
61
|
Luo C...Zhang H
|
28592292 |
2017 |
| 50 |
Channelopathies, genetic testing and risk stratification.
61
|
Wilde AAM...Amin A
|
28343764 |
2017 |
